Shuguang Wang Selected Research

Shuguang Wang Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 03/2004
10	Fibrosis (Cirrhosis) 01/2021 - 09/2008
6	Cholangiocarcinoma 10/2020 - 07/2010
6	Phototoxic Dermatitis (Phototoxicity) 01/2014 - 08/2004
5	Memory Disorders (Memory Loss) 03/2021 - 12/2017
5	Neoplasm Metastasis (Metastasis) 10/2020 - 05/2013
4	Wounds and Injuries (Trauma) 01/2022 - 10/2009
4	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 11/2009
3	Reperfusion Injury 02/2022 - 11/2009
3	Inflammation (Inflammations) 10/2021 - 01/2019
3	Hemorrhage 01/2021 - 09/2008
3	Pathologic Constriction (Stenosis) 12/2013 - 02/2009
2	Cicatrix (Scar) 04/2020 - 09/2017
2	Sleep Deprivation 12/2019 - 10/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2018 - 12/2017
2	Osteolysis 07/2018 - 11/2016
2	Carcinogenesis 10/2015 - 03/2004
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2021
1	Pneumonia (Pneumonitis) 10/2021
1	COVID-19 10/2021
1	Thrombosis (Thrombus) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Postoperative Hemorrhage 01/2021
1	Stroke (Strokes) 01/2021
1	Compression Fractures (Compression Fracture) 01/2021
1	Spondylosis 01/2021
1	Cholangitis 07/2020
1	Hyperplasia 07/2020
1	Heart Failure 05/2020
1	Plasmacytoma 05/2020
1	Cognitive Dysfunction 02/2020
1	Neuroinflammatory Diseases 02/2020
1	Sepsis (Septicemia) 11/2019
1	Aneurysm (Aneurysms) 08/2019
1	Intracranial Aneurysm (Cerebral Aneurysm) 08/2019
1	Amnesia (Dissociative Amnesia) 05/2019
1	Epilepsy (Aura) 01/2019

Drug/Important Bio-Agent (IBA)

4	Protein Hydrolysates FDA Link 03/2021 - 12/2017
3	Proteins (Proteins, Gene)FDA Link 02/2022 - 03/2004
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2014
3	Scopolamine (Hyoscine)FDA Link 03/2021 - 12/2017
3	Peptides (Polypeptides)IBA 03/2021 - 10/2018
3	Neuroprotective AgentsIBA 03/2021 - 10/2018
3	Long Noncoding RNAIBA 05/2020 - 01/2019
3	Laminin ReceptorsIBA 12/2016 - 05/2013
3	Small Interfering RNA (siRNA)IBA 10/2015 - 05/2013
2	HydrogelsIBA 01/2022 - 01/2021
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2020 - 01/2017
2	LipopolysaccharidesIBA 02/2020 - 01/2019
2	Cholinergic Agents (Cholinergics)IBA 05/2019 - 12/2017
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2009
2	TitaniumIBA 07/2018 - 11/2016
2	Tamoxifen FDA LinkGeneric 01/2018 - 01/2009
2	Hydroxyproline (4 Hydroxyproline)IBA 11/2017 - 10/2016
2	Therapeutic UsesIBA 01/2016 - 10/2012
2	WAY-362450IBA 06/2009 - 03/2009
1	Remifentanil (Ultiva)FDA Link 02/2022
1	Biological ProductsIBA 01/2022
1	Air Pollutants (Pollutants, Air)IBA 11/2021
1	gelatin methacryloylIBA 01/2021
1	SugarsIBA 01/2021
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2021
1	ResveratrolIBA 01/2021
1	Saline SolutionIBA 01/2021
1	Bone Cements (Bone Glue)IBA 01/2021
1	CarbohydratesIBA 01/2021
1	CelluloseIBA 01/2021
1	LigninIBA 01/2021
1	PhenolsIBA 01/2021
1	CateninsIBA 10/2020
1	tryptophylglycineIBA 02/2020
1	AntioxidantsIBA 12/2019
1	MicroRNAs (MicroRNA)IBA 11/2019
1	Circular RNAIBA 11/2019
1	Hemostatics (Antihemorrhagics)IBA 08/2019
1	glubranIBA 08/2019
1	PowdersIBA 08/2019
1	Thrombin FDA Link 08/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2019
1	Competitive Endogenous RNAIBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019

Therapy/Procedure

5	Laminectomy 01/2021 - 10/2016
4	Therapeutics 01/2022 - 02/2010
3	Liver Transplantation 09/2011 - 02/2009
2	Operative Time 01/2021 - 01/2021
2	Heterologous Transplantation (Xenotransplantation) 01/2021 - 05/2013
2	Punctures 01/2021 - 11/2019
2	Diskectomy (Discectomy) 01/2021 - 10/2016
2	Hepatectomy 07/2020 - 11/2009
2	Radiofrequency Ablation 11/2014 - 10/2012
1	Anesthesia 02/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Biological Dressings 11/2021
1	Topical Administration 01/2021
1	Microspheres (Microsphere) 01/2021
1	Vertebroplasty 01/2021
1	Perioperative Period 01/2021
1	Ligation 11/2019
1	Catheters 08/2019